Kissling E

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

Monge S, Humphreys J, Nicolay N, ..., Nunes B, VEBIS‐EHR Working Group

Influenza Other Respir Viruses 18 (4) e13292 [2024-04-00; online 2024-04-24]

Category: Vaccines Type: Journal article